Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
Swimming exercise ameliorates multiple sclerosis-induced impairment of short-term memory by suppressing apoptosis in the hippocampus of rats.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Smoking as a risk factor for multiple sclerosis.
A PheWAS approach in studying HLA-DRB1*1501.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.
Sex-specific environmental influences affecting MS development.
Neural networks to identify multiple sclerosis with optical coherence tomography.
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS.
Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions.
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.]
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Prophylactic and abundant intake of α-lipoic acid causes hepatic steatosis and should be reconsidered in usage as an anti-aging drug.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis.
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis.
A role for human brain pericytes in neuroinflammation.
Pages
« first
‹ previous
…
431
432
433
434
435
436
437
438
439
…
next ›
last »